Related Experiment Video
Updated: Mar 6, 2026
09:16
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
15.9K
Methamphetamine: Effects on the brain, gut and immune system.
Monica D Prakash1, Kathy Tangalakis1, Juliana Antonipillai1
1Immunology in Chronic Diseases Program, Centre for Chronic Disease, College of Health and Biomedicine, Victoria University, Melbourne, Australia.
Pharmacological Research
|March 18, 2017
Summary
Methamphetamine (METH) abuse is a global problem affecting the nervous, immune, and gut systems. Understanding these cellular effects may lead to new treatments for METH-induced neuropsychiatric disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Immunology
Background:
- Methamphetamine (METH) is a potent stimulant with short-term benefits but severe long-term consequences.
- Chronic METH use is linked to psychosis, depression, and behavioral issues.
- METH abuse is a significant global health concern.
Purpose of the Study:
- To explore the interconnected cellular effects of METH on multiple body systems.
- To investigate the potential contribution of these effects to neuropsychiatric disorders.
- To identify therapeutic targets for mitigating METH's adverse impacts.
Main Methods:
- Review of cellular mechanisms of METH action.
- Analysis of METH's impact on the central nervous system, peripheral nervous system, immune system, and gastrointestinal system.
- Development of a model linking METH-induced systemic effects to neuropsychiatric pathogenesis.
Main Results:
- METH exerts widespread cellular effects across nervous, immune, and gastrointestinal systems.
- These systemic effects are potentially linked to the development of METH-induced neuropsychiatric disorders.
- A model is proposed to explain the pathogenesis of these disorders.
Conclusions:
- Targeting the identified pathways may offer therapeutic strategies against METH's harmful effects.
- This model could inform treatments for other conditions involving gut, nervous, and immune system dysregulation.
- Further research into these interconnected systems is warranted for novel therapeutic interventions.
Related Concept Videos
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.0K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.0K
01:23Drugs Acting on Autonomic Ganglia: Stimulants
2.2K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.2K
01:29Stimulants
1.1K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.1K
01:29Drugs Affecting Neurotransmitter Synthesis
2.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.4K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.7K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.7K
01:15Drug Abuse and Addiction: Pharmacological Phenomena
1.4K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.4K